Evidence mapPaperPMID 39706273Full record

ArticleThe Journal of biological chemistry2025

PRDX4 mitigates diabetic retinopathy by inhibiting reactive gliosis, apoptosis, ER stress, oxidative stress, and mitochondrial dysfunction in Müller cells.

Yue Huang, Yuting Zhang, Yuan Liu, Yinan Jin, Hongwei Yang

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yue HuangDepartment of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Yuting ZhangDepartment of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Yuan LiuDepartment of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Yinan JinDepartment of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Hongwei YangDepartment of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China. Electronic address: yanghw@sj-hospital.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a neurovascular complication of diabetes. As a crucial player in the retinal physiology, Müller cells are affected in DR, impairments of Müller cell function lead to retinal malfunctions. Therefore, searching for approaches to mitigate diabetes-induced injury in Müller cells is imperative for delaying DR. Peroxiredoxin 4 (PRDX4), an important endoplasmic reticulum (ER)-resident antioxidant, was explored in this study for its potential protective role against DR. Streptozotocin-induced mouse model of diabetes and high glucose (HG)-induced Müller cells were utilized to assess the impact of PRDX4. Compared with WT mice, PRDX4 knockout exacerbated retinal neurodegeneration, reactive gliosis, cell apoptosis, ER stress, oxidative stress, and mitochondrial dysfunction in diabetic retinas. Knockdown of PRDX4 aggravated HG-induced reactive gliosis, apoptosis, ER stress, oxidative stress, and mitochondrial dysfunction in Müller cells. Conversely, PRDX4 overexpression in Müller cells protected against HG-induced cell damage. Mechanistically, PRDX4 promoted the degradation of dipeptidyl peptidase-4, which is associated with DR in type 1 diabetics, thereby alleviating HG-stimulated Müller cell abnormalities. Our study indicated that PRDX4 is a crucial protective regulator in DR progression via destabilization of dipeptidyl peptidase-4 protein and suggested that enhancement of PRDX4 level may represent a promising approach for treating DR.

Indexed as

ApoptosisDiabetic RetinopathyEndoplasmic Reticulum StressEpendymoglial CellsGliosisMitochondriaOxidative StressPeroxiredoxinsAnimalsDiabetes Mellitus, ExperimentalMaleMiceMice, Inbred C57BLMice, KnockoutPeroxiredoxinsPrdx4 protein, mousediabetic retinopathyendoplasmic reticulum stressmitochondrial dysfunctionMüller cellPRDX4reactive gliosis

Identifiers

PMID39706273
PMCPMC11760821

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.